ZA989241B - Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptides - Google Patents
Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptidesInfo
- Publication number
- ZA989241B ZA989241B ZA989241A ZA989241A ZA989241B ZA 989241 B ZA989241 B ZA 989241B ZA 989241 A ZA989241 A ZA 989241A ZA 989241 A ZA989241 A ZA 989241A ZA 989241 B ZA989241 B ZA 989241B
- Authority
- ZA
- South Africa
- Prior art keywords
- pseudotetrapeptides
- azacycloalkylalkanoyl
- preparation
- azacycloalkylalkanoyl pseudotetrapeptides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/021—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06104—Dipeptides with the first amino acid being acidic
- C07K5/06113—Asp- or Asn-amino acid
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6171997P | 1997-10-10 | 1997-10-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA989241B true ZA989241B (en) | 1999-06-04 |
Family
ID=22037674
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA989241A ZA989241B (en) | 1997-10-10 | 1998-10-09 | Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptides |
Country Status (18)
Country | Link |
---|---|
US (1) | US6180759B1 (no) |
EP (1) | EP1030831A4 (no) |
JP (1) | JP2001519411A (no) |
KR (1) | KR20010024467A (no) |
CN (1) | CN1278791A (no) |
AP (1) | AP1057A (no) |
AU (1) | AU738114B2 (no) |
BG (1) | BG104408A (no) |
BR (1) | BR9814068A (no) |
CA (1) | CA2306823A1 (no) |
EA (1) | EA002724B1 (no) |
HU (1) | HUP0003788A3 (no) |
IL (1) | IL135553A0 (no) |
NO (1) | NO20001793D0 (no) |
OA (1) | OA11369A (no) |
PL (1) | PL340915A1 (no) |
SK (1) | SK4332000A3 (no) |
ZA (1) | ZA989241B (no) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0923553B1 (en) * | 1996-08-21 | 2008-03-26 | Aventis Pharmaceuticals Inc. | Stable non-hygroscopic crystalline form of n- n-n-(4-(piperidin-4-yl)butanoyl)-n-ethylglycyl compounds |
CN100422147C (zh) * | 2002-11-01 | 2008-10-01 | 北京天衡药物研究院 | 一种制备0-取代磺酰酪氨酸类化合物的方法 |
KR100841409B1 (ko) * | 2003-12-16 | 2008-06-25 | 에스케이케미칼주식회사 | 암로디핀 겐티세이트 염과 이의 제조방법 |
CN103254265B (zh) * | 2012-02-21 | 2016-07-13 | 上海希迈医药科技有限公司 | 醋酸阿比特龙三氟乙酸盐及其制备方法和应用 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1042487A (en) * | 1964-06-25 | 1966-09-14 | Ici Ltd | Polypeptide derivatives |
JPS6322081A (ja) * | 1986-07-11 | 1988-01-29 | Kissei Pharmaceut Co Ltd | 新規なアミノ酸誘導体 |
CA2008116C (en) * | 1989-02-23 | 2001-11-20 | Thomas Weller | Glycine derivatives |
IE902238A1 (en) * | 1989-06-30 | 1991-01-16 | Abbott Lab | Tetrapeptide type-b cck receptor ligands |
IE914334A1 (en) * | 1990-12-17 | 1992-06-17 | Black James Foundation | Tetrapeptide derivatives and analogues |
UA44258C2 (uk) * | 1993-10-15 | 2002-02-15 | Рон-Пуленк Рорер Фармасьютікалз Інк. | Антитромботичні азациклоалкілалканоілпептиди та псевдопептиди, фармацевтична композиція, що їх містить, спосіб профілактики або лікування тромбозу у ссавців (варіанти) |
US5780590A (en) * | 1993-10-15 | 1998-07-14 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |
GB9516994D0 (en) * | 1995-08-18 | 1995-10-18 | Iaf Biochem Int | Solution synthesis of peripheral acting analgestic opioid tetrapeptides |
EP0768384B1 (en) * | 1995-10-11 | 2001-06-13 | Holland Sweetener Company V.o.F. | Improved enzymatic coupling reaction of N-protected-L-aspartic acid and phenylalanine methyl ester |
EP0923553B1 (en) * | 1996-08-21 | 2008-03-26 | Aventis Pharmaceuticals Inc. | Stable non-hygroscopic crystalline form of n- n-n-(4-(piperidin-4-yl)butanoyl)-n-ethylglycyl compounds |
NL1005808C2 (nl) * | 1997-04-14 | 1998-10-19 | Dsm Nv | Hexahydro-aspartaamamiden en werkwijze voor de bereiding ervan. |
-
1998
- 1998-10-09 ZA ZA989241A patent/ZA989241B/xx unknown
- 1998-10-09 IL IL13555398A patent/IL135553A0/xx unknown
- 1998-10-09 JP JP2000515867A patent/JP2001519411A/ja active Pending
- 1998-10-09 CA CA002306823A patent/CA2306823A1/en not_active Abandoned
- 1998-10-09 AP APAP/P/2000/001781A patent/AP1057A/en active
- 1998-10-09 HU HU0003788A patent/HUP0003788A3/hu unknown
- 1998-10-09 SK SK433-2000A patent/SK4332000A3/sk unknown
- 1998-10-09 EA EA200000399A patent/EA002724B1/ru not_active IP Right Cessation
- 1998-10-09 PL PL98340915A patent/PL340915A1/xx unknown
- 1998-10-09 BR BR9814068-0A patent/BR9814068A/pt not_active IP Right Cessation
- 1998-10-09 KR KR1020007003829A patent/KR20010024467A/ko not_active Application Discontinuation
- 1998-10-09 EP EP98953345A patent/EP1030831A4/en not_active Withdrawn
- 1998-10-09 CN CN98810983A patent/CN1278791A/zh active Pending
- 1998-10-09 AU AU10746/99A patent/AU738114B2/en not_active Ceased
-
2000
- 2000-03-31 OA OA1200000096A patent/OA11369A/en unknown
- 2000-04-06 NO NO20001793A patent/NO20001793D0/no not_active Application Discontinuation
- 2000-04-07 US US09/544,680 patent/US6180759B1/en not_active Expired - Fee Related
- 2000-05-08 BG BG104408A patent/BG104408A/bg unknown
Also Published As
Publication number | Publication date |
---|---|
US6180759B1 (en) | 2001-01-30 |
EA002724B1 (ru) | 2002-08-29 |
CN1278791A (zh) | 2001-01-03 |
CA2306823A1 (en) | 1999-04-22 |
AP1057A (en) | 2002-04-08 |
PL340915A1 (en) | 2001-03-12 |
BG104408A (bg) | 2000-12-29 |
SK4332000A3 (en) | 2000-12-11 |
JP2001519411A (ja) | 2001-10-23 |
BR9814068A (pt) | 2000-09-26 |
IL135553A0 (en) | 2001-05-20 |
KR20010024467A (ko) | 2001-03-26 |
AP2000001781A0 (en) | 2000-06-30 |
HUP0003788A2 (hu) | 2001-04-28 |
AU1074699A (en) | 1999-05-03 |
OA11369A (en) | 2004-01-27 |
NO20001793L (no) | 2000-04-06 |
HUP0003788A3 (en) | 2001-05-28 |
NO20001793D0 (no) | 2000-04-06 |
AU738114B2 (en) | 2001-09-06 |
EA200000399A1 (ru) | 2000-10-30 |
EP1030831A4 (en) | 2003-01-02 |
EP1030831A1 (en) | 2000-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9602957A2 (en) | Process for the preparation of dihalo- and dihidroxi-azolopyrimidines | |
EP0699695A3 (de) | Verfahren zur Herstellung von Polyacetalcopolymeren | |
IL129759A0 (en) | Process for the preparation of benzyl-ethers | |
ZA954324B (en) | Process for the preparation of 3-aryluracils | |
ZA9810669B (en) | Process for the preparation of 8-methoxy-quinolone-carbyxylic acids | |
IL129906A0 (en) | Process for the preparation of beta-isophorone | |
HUP0003737A3 (en) | New process for the preparation of omeprazole | |
IL121730A0 (en) | Process for the preparation of 2'-fluoro-5-methyl-beta-L-arabino-furanosyluridine | |
HK1028619A1 (en) | Process for the preparation of a polyamide-polyurethane micro-blend | |
IL133140A0 (en) | Novel process for the preparation of 4-aryl-piperidines | |
GB9509826D0 (en) | Process for the preparation of imidazolutidine | |
HUP9903852A3 (en) | Process for the preparation of contrast agents | |
HUP0003452A3 (en) | Process for the preparation of 1-aryl-3-cyclopropyl-1,3-propanediones | |
ZA982255B (en) | Process for the preparation of arylmalonates. | |
ZA987741B (en) | Process for the preparation of oxazaphosphorine-2-amines | |
IL120715A0 (en) | Process for the preparation of trifluoroethoxy-arenecarboxylic acids | |
IL128026A0 (en) | Process for the preparation of hexanitrohexa-azaisowurtzitanes | |
GR3035436T3 (en) | Process for the preparation of 2-H-heptafluoropropane | |
HUP0001757A3 (en) | Improved process for the preparation of halo-4-phenoxyquinolines | |
IL135553A0 (en) | Process for the preparation of azacycloalkyalkanoyl pseudotetrapeptides | |
HRP970710A2 (en) | Process for the preparation of 1-alkylpyrazole-5-carboxylic esters | |
HUP9902745A2 (en) | Process for the preparation of benzylcarbazate | |
ZA9510894B (en) | Process for the preparation of chloromethylpyridines | |
IL116493A0 (en) | Process for the preparation of sameridine | |
GB9807032D0 (en) | Process for the preparation of (S)-3-carbethoxy-3-benzylpiperidine |